Mucosan Retard (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucosan Retard, is a mucolytic presented as an oral formulation for oral use. It helps reduce the viscosity of bronchial secretions and facilitates their clearance in patients with productive coughs and other respiratory conditions.

GNH USA supplies Mucosan Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability and regulatory compliance across EU and other markets.

Ambroxol Hydrochloride is used as a mucolytic agent to improve clearance of thick bronchial secretions in several respiratory conditions.

- Productive cough: helps loosen and expel mucus, reducing cough frequency. - Acute bronchitis: facilitates mucus clearance, supporting faster symptom resolution. - Chronic obstructive pulmonary disease (COPD): reduces sputum viscosity, aiding airway patency. - Respiratory tract infections with thick mucus: improves expectoration and eases breathing.

Adverse reactions to Ambroxol Hydrochloride are generally mild but may occur.

Common Side Effects: - Nausea: mild stomach upset often transient. - Taste alteration: temporary bitter or metallic taste. - Abdominal discomfort: mild cramps or pain. - Diarrhea: loose stools. - Headache: mild to moderate. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Allergic reactions: hives, swelling, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: signs of liver dysfunction. - Eosinophilia: elevated eosinophil count. - Neutropenia: reduced white blood cell count. - Bronchospasm: worsening breathing difficulty.

When prescribing Ambroxol Hydrochloride, several safety considerations should be observed. - Assess renal function: dose may need adjustment in severe renal impairment. - Use with caution in asthma: monitor for bronchospasm. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Monitor gastrointestinal bleeding: especially with concurrent NSAIDs. - Pregnancy and lactation: consult a physician before use. - Store at room temperature: keep in the original pack, protect from moisture.

Ambroxol Hydrochloride can interact with other medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase ambroxol plasma concentrations. - Concurrent use with other mucolytics: risk of excessive mucus thinning. - Antitussives containing codeine: may counteract expectorant effect.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): monitor INR for possible changes. - Bronchodilators (e.g., beta‑agonists): observe for additive respiratory effects. - Macrolide antibiotics: may increase gastrointestinal side effects.